Thermo launches next-generation, compressor-free plate sealer

28 Jan 2020

Features new functionalities and capabilities making it versatile for a variety of both manual and automated microplate processing life science applications.

Thermo Fisher Scientific has launched its next-generation, compressor-free plate sealer, designed to alleviate the maintenance burden on operators, while offering unparalleled process customization capabilities, intuitive operation and significant work efficiencies.

Thermo launches next-generation, compressor-free plate sealer
The Thermo Scientific ALPS 5000 Plate Sealer.

Biotechnology, pharmaceutical and academic research laboratories can now benefit from a system capable of simplifying the plate sealing process and enabling improved reliability and productivity for both stand-alone, as well as, integrated robotic projects.

As a fully electrically operated system, the Thermo Scientific ALPS 5000 has been developed to increase the efficiency of the heat plate sealing process and offers maximum flexibility to support high-throughput applications. The system eliminates the need for tedious and costly replacement of expensive vacuum cups, onboard compressors and compressed air lines, typically required when using conventional pneumatically driven equipment. As a result, maintenance costs are minimized and quieter operation is enabled ensuring minimal disruption to the working environment. Designed as one of the most user-friendly units available on the market, the ALPS 5000 facilitates easy, tool-free foil loading and does not require the use of adapters to change between different plates. The system is operated via a large intuitive touchscreen with a modern user interface, which allows for precise control over sealing parameters to ensure repeatability, while including programming parameters for integration into automation or robotic workflows.

The ALPS 5000 offers superior process customization capabilities to address varying application needs, from polymerase chain reaction and high-performance liquid chromatography to next-generation sequencing, compound storage and flow cytometry. Users can program the sealing time, temperature and pressure parameters to suit their specific requirements. They can also choose the most appropriate sealing foil length, opting for a longer foil to improve pealing or a shorter one to reduce foil usage by up to 10%. Moreover, the ALPS 5000 offers the flexibility to use either a traditional force sealing, or a distance sealing to maximize the number of times a plate can be resealed.

"Reliable plate sealing is essential to researchers who wish to avoid unnecessary experiment repeats and data inconsistency due to sample contamination and evaporation," explains Sung Dae Hong, vice president and general manager for laboratory plastics essentials at Thermo Fisher Scientific. "With storage requirements and laboratory processes becoming increasingly complicated, scientists and researchers are looking for solutions that can simplify their day-to-day operations and meet their specific application needs. Our new ALPS 5000 Plate Sealer has been developed to do just that, streamlining the plate sealing process, improving reproducibility and minimizing maintenance requirements, while preserving precious research."

The ALPS 5000 offers fast sealing times, being able to seal up to four plates per minute. It also features a compact footprint to save valuable bench space. Furthermore, the ALPS 5000 has been equipped with an Eco Mode, which triggers a temperature reduction down to 30C° when the system has been inactive for a pre-specified amount of time, allowing for considerable energy savings.

Read More

Related news

Ajinomoto introduces fast track platform for drug product manufacturing

Ajinomoto introduces fast track platform for drug product manufacturing

30 Jun 2020

AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

Read more 
Piramal acquires solid oral dosage drug product facility from G&W Laboratories

Piramal acquires solid oral dosage drug product facility from G&W Laboratories

22 Jun 2020

The site can also produce liquids, creams, and ointments, further expanding the CDMO's portfolio.

Read more 
Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment

Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment

22 Jun 2020

The CDMO will work on developing a solution and a solid oral dosage form of ViralClear's merimepodib.

Read more 
Sanofi to build EUR 490 million vaccine production facility in France

Sanofi to build EUR 490 million vaccine production facility in France

16 Jun 2020

The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines

Read more 
Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's

Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's

8 Jun 2020

Optimizing the dosage form's efficiency reduces the amount of drug required in each patch.

Read more 
Emergent bags $628 million landmark CDMO deal to produce COVID-19 vaccine candidates

Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates

2 Jun 2020

The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.

Read more 
Changes needed to prevent controversial pay-for-delay pharma deals

Changes needed to prevent controversial pay-for-delay pharma deals

26 May 2020

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Read more 
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

26 May 2020

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Read more 
AbCellera and Lilly seal multi-year antibody discovery collaboration

AbCellera and Lilly seal multi-year antibody discovery collaboration

25 May 2020

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Read more 
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

25 May 2020

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

Read more